MSGUX | VIGAX | MSGUX / VIGAX | |
Total Expense Ratio | 1.62 | 0.05 | 3,240% |
Annual Report Gross Expense Ratio | 1.62 | 0.05 | 3,240% |
Fund Existence | 10 years | 25 years | - |
Gain YTD | 29.679 | 16.594 | 179% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4.75B | 342B | 1% |
Annual Yield % from dividends | 0.00 | 0.42 | - |
Returns for 1 year | 61.05 | 22.80 | 268% |
Returns for 3 years | 105.31 | 119.38 | 88% |
Returns for 5 years | -31.58 | 102.24 | -31% |
Returns for 10 years | 39.96 | 352.59 | 11% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FBDIX | 161.38 | 1.46 | +0.91% |
Franklin Biotechnology Discovery A | |||
SPFIX | 83.74 | 0.44 | +0.53% |
Shelton S&P 500 Index Investor | |||
PAECX | 20.10 | 0.06 | +0.30% |
Putnam Dynamic Asset Allocation Gr C | |||
WWSAX | 22.23 | 0.05 | +0.23% |
Keeley Small Cap Fund A | |||
MRSGX | 24.35 | -0.02 | -0.08% |
MFS Research International R1 |